£3m invested in MyWay Digital Health
Foresight Group, a leading regional private equity and infrastructure investment manager, has announced a £3 million investment into MyWay Digital Health Ltd, a digital healthcare
Foresight Group, a leading regional private equity and infrastructure investment manager, has announced a £3 million investment into MyWay Digital Health Ltd, a digital healthcare
A case study has shown how inequality in access to diabetes technologies has been overcome though a Diabetes Intervention Worker Pilot by Somerset NHS Foundation
Roche has announced that it plans to invest up to $550m to expand its continuous glucose monitoring (CGM) site in the US. The company plans
Sequel Med Tech has announced that it has agreed to integrate its twiist automated insulin delivery system with Abbott‘s glucose-ketone sensor, which is currently under
A new device based on research from Indiana University could one day supplement current methods to provide better protection against more serious swings in blood
Insulet Corporation has announced that its Omnipod 5 is now compatible with the Dexcom G7 Continuous Glucose Monitor (CGM) in the UK and Netherlands. The
IR-MED has secured a $500,000 grant from the Israel Innovation Authority (IIA) to advance the development of DiaSafe, an AI-powered device which uses noninvasive spectrographic
A study has found that a new technology that allows a artificial pancreas system to adapt to users’ changing bodies – and lets users test
A new partnership has led to the development of the first-ever automated insulin delivery (AID) system that incorporates a one-year glucose sensor. Sequel Med Tech,
A new partnership has led to the development of the first-ever automated insulin delivery (AID) system that incorporates a one-year glucose sensor. Sequel Med Tech,